GlassScriptPhysician profile
Kyle L Vaughn
NPI 1467618850
$109,695.46
in general payments reported to CMS, 2019-2025
41 companies · $2,264 in 2025
The $2,264 reported for 2025 was more than what 85% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $12K · 2021: $16K · 2022: $28K · 2023: $21K · 2024: $18K · 2025: $2,264.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $33K · Food and Beverage: $5,044 · Travel and Lodging: $3,556.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $32,933.11 |
| Food and Beverage | $5,043.56 |
| Travel and Lodging | $3,556.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Anika Therapeutics, INC. | $20,797.18 | 2021-2024 | Integrity, Drawtight, Toe Motion |
| Ortho Solutions INC | $19,786.53 | 2022-2025 | |
| Medshape, INC. | $19,498.60 | 2021-2025 | |
| Nvision Biomedical Technologies, INC. | $13,988.63 | 2020-2021 | |
| Accufix Surgical INC. | $6,295.91 | 2023-2025 | Accu-Joint, Accu-Joint |
| Wright Medical Technology, INC. | $6,269.24 | 2019-2020 | |
| Stryker Corporation | $3,820.18 | 2019-2025 | Prophecy, Ortholoc 2 Lapifuse, Inbone |
| Trilliant Surgical LLC. | $3,312.48 | 2020-2022 | |
| Goode Surgical INC | $2,972.83 | 2019 | |
| Arthrex, INC. | $2,771.43 | 2019-2020 | |
| In2bones USA, LLC | $2,523.32 | 2019-2021 | |
| Impactortho, INC. | $2,273.84 | 2020-2024 | |
| Zimmer Biomet Holdings, INC. | $1,098.82 | 2020-2025 | Tapestry, Juggerknotless Soft Anchor |
| Arthrosurface Incorporated | $1,055.15 | 2019-2020 | |
| Crossroads Extremity Systems, LLC | $750.23 | 2019 |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kuros Biosciences USA, INC | $248.11 | 2025 | Magnetos |
| Orthofix Medical, INC. | $229.31 | 2019-2025 | Physio-Stim |
| Abbott Laboratories | $209.30 | 2024-2025 | Octrode |
| Encore Medical, LP | $196.46 | 2021-2022 | |
| Treace Medical Concepts, INC. | $178.71 | 2021-2024 | |
| Horizon Therapeutics Plc | $178.60 | 2023 | Krystexxa |
| Gramercy Extremity Orthopedics LLC | $127.58 | 2021 | |
| Organogenesis INC. | $117.71 | 2022-2024 | |
| Ultragenyx Pharmaceutical INC. | $117.64 | 2020 | |
| Kerecis Limited | $106.03 | 2021 | |
| Restor3d, INC. | $105.86 | 2022 | |
| Carbofix Orthopedics INC | $103.04 | 2019 | |
| Medline Industries LP | $83.72 | 2021 | |
| Amgen INC. | $82.29 | 2024-2025 | Krystexxa |
| Flower Orthopedics Coporation | $75.00 | 2022 | |
| Bioventus LLC | $57.96 | 2019-2025 | Exogen Ultrasound Bone Healing System |
| Smith+Nephew, INC. | $43.69 | 2022-2024 | Bone Anchors With Arthroscopic Delivery System |
| Integra Lifesciences Corporation | $39.99 | 2019-2020 | |
| Nevro Corp. | $38.60 | 2022-2023 | Senza |
| Djo, LLC | $35.84 | 2023 | Cmf |
| Forthright Medical - Az, LLC | $24.34 | 2024 | |
| Arteriocyte Medical Systems, INC. | $21.52 | 2019 | |
| Kci USA, INC. | $17.04 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $14.86 | 2023 | Seglentis |
| Biotissue Holdings INC. | $14.70 | 2021 | |
| Amniox Medical, INC. | $13.19 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Vaughn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.